ADGI NASDAQ
Adagio Therapeutics, Inc.
1W: -2.9%
1M: +23.7%
3M: +56.8%
1Y: -91.4%
$4.64
Last traded 2022-09-12 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$58M
Revenue
+20.4% YoY
$-107M
Net Income
-369.6% YoY
$-110M
Free Cash Flow
+24.9% YoY
91.1%
Gross Margin
-320.8%
Op. Margin
-310.8%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-95.9%
ROA-69.7%
ROIC-302.5%
Valuation
P/E-11.8
P/B8.2
EV/EBITDA-24.3
Leverage
Debt/Equity0.05
Current Ratio5.87
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z17.88
Beneish M-2.31